Poractant Alfa Versus Beractant for Neonatal Respiratory Distress Syndrome: A Retrospective Cost Analysis.
J Pediatr Pharmacol Ther
; 23(5): 367-371, 2018.
Article
in En
| MEDLINE
| ID: mdl-30429690
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
/
Observational_studies
Language:
En
Journal:
J Pediatr Pharmacol Ther
Year:
2018
Document type:
Article
Country of publication:
United States